Submitted by Anonymous (not verified) on 19 May 2026 - 10:08
Human medicines European public assessment report (EPAR): Ibrance, palbociclib, Date of authorisation: 09/11/2016, Revision: 25, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Ibrance, palbociclib, Date of authorisation: 09/11/2016, Revision: 25, Status: Authorised